EHF
ETS homologous factor
Also known as: EHF_HUMAN, ESE3, ESEJ
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NZC4
- Gene
- EHF
- Ensembl
- ENSG00000135373
- Chromosome
- 11
- Canonical length
- 300 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Golgi apparatus
OverviewNCBI Gene
This gene encodes a protein that belongs to an ETS transcription factor subfamily characterized by epithelial-specific expression (ESEs). The encoded protein acts as a transcriptional repressor and may be involved in epithelial differentiation and carcinogenesis. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2011]
Canonical amino-acid sequenceUniProt
300 residues, UniProt reviewed canonical sequence.
>Q9NZC4|EHF
1 MILEGGGVMN LNPGNNLLHQ PPAWTDSYST CNVSSGFFGG QWHEIHPQYW TKYQVWEWLQ
61 HLLDTNQLDA NCIPFQEFDI NGEHLCSMSL QEFTRAAGTA GQLLYSNLQH LKWNGQCSSD
121 LFQSTHNVIV KTEQTEPSIM NTWKDENYLY DTNYGSTVDL LDSKTFCRAQ ISMTTTSHLP
181 VAESPDMKKE QDPPAKCHTK KHNPRGTHLW EFIRDILLNP DKNPGLIKWE DRSEGVFRFL
241 KSEAVAQLWG KKKNNSSMTY EKLSRAMRYY YKREILERVD GRRLVYKFGK NARGWRENENLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EHF can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 271 nTPM
Expression across tissuesHPA
Tissue
- salivary gland: 271 nTPM
- esophagus: 196 nTPM
- breast: 186 nTPM
- seminal vesicle: 145 nTPM
- fallopian tube: 122 nTPM
- rectum: 119 nTPM
Single-cell type
- esophageal apical cells: 3,810 nCPM
- lacrimal acinar cells: 2,265 nCPM
- salivary acinar cells: 1,081 nCPM
- breast lactating cells: 972 nCPM
- endometrial glandular cells: 878 nCPM
- epididymal basal cells: 876 nCPM
Immune cell
- myeloid DC: 1.7 nTPM
- classical monocyte: 0.1 nTPM
- basophil: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- white matter: 9.8 nTPM
- midbrain: 8.8 nTPM
- medulla oblongata: 6.3 nTPM
- spinal cord: 5.7 nTPM
- pons: 4.6 nTPM
- basal ganglia: 3.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.43
- gnomAD pLI
- 0.71
- gnomAD missense Z
- 1.04
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- epithelial cell differentiation
- positive regulation of transcription by RNA polymerase II
- regulation of transcription by RNA polymerase II
Molecular functions
- DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EHF as an antibody target. Whether an autoantibody or antibody against EHF could matter depends on whether native EHF is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EHF is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EHF as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...